* OrthoPediatrics Corp KIDS.OQ KIDS.O is expected to show a
rise in quarterly revenue when it reports results on November
3.
* The Warsaw Indiana, Indiana-based company is expected to
report a 18.4% increase in revenue to $26.285 million from
$22.21 million a year ago, according to the mean estimate from 7
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for OrthoPediatrics Corp is
for a loss of 28 cents per share. For the same quarter last
year, the company reported a loss of 24 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for OrthoPediatrics
Corp is $78, about 9.8% above its last closing price
of $70.39.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Jun. 302021 -0.35 -0.34 -0.19 Beat 44.8
Mar. 312021 -0.27 -0.27 -0.47 Missed -76.5
Dec. 312020 -0.36 -0.27 -0.73 Missed -168.4
Sep. 302020 -0.31 -0.31 -0.24 Beat 21.6
Jun. -0.38 -0.38 -0.49 Missed -28
302020
Mar. 312020 -0.26 -0.25 -0.30 Missed -18.6
Dec. 312019 -0.25 -0.25 -0.36 Missed -44
Sep. 302019 -0.18 -0.18 -0.18 Met -2.7
This summary was machine generated November 2 at 02:07 GMT. All
figures in US dollars unless otherwise stated